Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Immuneering Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −1 vs. Q3 2021
- Shares held
- 12.5M
- +395.7K (+3.3%) vs. Q3 2021
- Total value
- $200.1M
- −$116.3M (−36.8%) vs. Q3 2021
- New holders
- 4
- 20 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 76 | $1.00K | 0.00% | +76 | New |
| Ameritas Investment Partners, Inc. | 634 | $10.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 774 | $13.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,310 | $21.0K | 0.00% | +1,077+462.2% | Added |
| UBS Group AG | 1,620 | $26.0K | 0.00% | +501+44.8% | Added |
| STRS Ohio | 1,900 | $30.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,962 | $32.0K | 0.00% | +1,090+125.0% | Added |
| Citigroup Inc | 2,958 | $48.0K | 0.00% | +1,712+137.4% | Added |
| American International Group, Inc. | 4,468 | $72.0K | 0.00% | −58−1.3% | Reduced |
| California State Teachers Retirement System | 4,468 | $72.0K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 4,637 | $75.0K | 0.00% | +2,937+172.8% | Added |
| Deutsche Bank AG | 5,022 | $81.0K | 0.00% | +270+5.7% | Added |
| JPMorgan Chase & Co | 5,454 | $88.0K | 0.00% | +2,287+72.2% | Added |
| Bank of America Corp | 7,732 | $125.0K | 0.00% | +7,190+1,326.6% | Added |
| Allspring Global Investments Holdings, LLC | 9,228 | $149.0K | 0.00% | +9,228 | New |
| Wells Fargo & Company | 10,190 | $165.0K | 0.00% | +10,146+23,059.1% | Added |
| Morgan Stanley | 10,637 | $172.0K | 0.00% | +3,929+58.6% | Added |
| Goldman Sachs Group Inc | 13,162 | $213.0K | 0.00% | +13,162 | New |
| Nuveen Asset Management, LLC | 11,760 | $247.0K | 0.00% | 00.0% | Unchanged |
| Kore Private Wealth LLC | 18,100 | $293.0K | 0.04% | +4,000+28.4% | Added |
| Charles Schwab Investment Management Inc | 21,397 | $346.0K | 0.00% | +1,161+5.7% | Added |
| Bank of New York Mellon Corp | 23,875 | $386.0K | 0.00% | +3,276+15.9% | Added |
| Millennium Management LLC | 29,756 | $481.0K | 0.00% | −60,032−66.9% | Reduced |
| TD Asset Management Inc | 34,296 | $555.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 75,891 | $1.23M | 0.00% | +3,279+4.5% | Added |
| FMR LLC | 81,704 | $1.32M | 0.00% | −168,296−67.3% | Reduced |
| State Street Corp | 119,941 | $1.94M | 0.00% | +18,739+18.5% | Added |
| Geode Capital Management, LLC | 133,815 | $2.16M | 0.00% | +11,496+9.4% | Added |
| Suvretta Capital Management, LLC | 200,000 | $3.23M | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 313,913 | $5.08M | 0.00% | −29,688−8.6% | Reduced |
| Adage Capital Partners GP, L.L.C. | 314,000 | $5.08M | 0.01% | +314,000 | New |
| Perceptive Advisors LLC | 681,051 | $11.0M | 0.17% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 1,089,816 | $17.6M | 0.41% | 00.0% | Unchanged |
| BlackRock Inc. | 1,716,170 | $27.8M | 0.00% | +191,796+12.6% | Added |
| Citadel Advisors LLC | 2,058,102 | $32.0M | 0.03% | +2,643+0.1% | Added |
| Cormorant Asset Management, LP | 2,302,626 | $37.2M | 2.21% | +50,000+2.2% | Added |
| Price T Rowe Associates Inc | 3,188,505 | $50.7M | 0.00% | +74,480+2.4% | Added |
| Caas Capital Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −13,149−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −3,719−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,814−100.0% | Sold out |